The Coca-Cola Company has confirmed plans to shut its factory in Massachusetts by the end of this year.
Located in Northampton, the plant produces non-carbonated beverages including teas and juices and employs 175 people, a company spokesperson told Just Drinks.
“While employees have been aware of these plans for some time, the company is issuing formal notices now to provide as much advance notice as possible.
"The company is committed to supporting employees through this transition, including working closely with the state to identify new job opportunities," they added.
Just Drinks has asked for further details, including on why the company is closing the facility.
According to earlier local media reports, the group had previously planned to close the site in 2023.
In April last year, Coca-Cola announced plans to close one of its bottling facilities in American Canyon, California.
The company intended to shut the plant in June and transfer the volume to a third-party co-packer in the area.
Coca-Cola works with a network of five bottling partners across North America, according to its website. These include Swire, Coca-Cola Southwest Beverages, Reyes Coca-Cola Bottling and Coca-Cola Canada Bottling.
In its first quarter results, released at the end of April, the soft drinks giant posted net revenues of $12.5bn, a 12% increase year-over-year.
Total operating income soared 19% in the quarter, “which included items impacting comparability and currency tailwinds”, the company said.
North America operating income increased 20%, supported by 4% unit case volume growth - led by Trademark Coca-Cola, water, sports drinks, coffee, and tea -alongside 1% price/mix growth.
In the fourth quarter, the Coca-Cola Company reported net revenues of $11.8bn, up 2% from the prior year. Fourth-quarter operating income fell 32% due to a non-cash $960m impairment charge related to the Bodyarmor trademark.
In North America, revenues rose 4% year-over-year, driven by 1%-unit case volume growth and 4% price/mix growth, although regional operating income dropped 65% due to the impairment.
For the full year 2025, the company generated net revenues of $47.9bn, up 2%, while operating profit grew 38%.
